148 related articles for article (PubMed ID: 19711437)
1. A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Kushner BH; Kramer K; Modak S; Akhurst TJ; Cheung NK
Pediatr Blood Cancer; 2009 Dec; 53(7):1340-2. PubMed ID: 19711437
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma involvement of the falx cerebri.
Quackenbush KE; Luna-Fineman S; Magee JF; Gundogan M; Golobi M; Irie T; Fernandez CV
Pediatr Blood Cancer; 2009 Dec; 53(7):1337-9. PubMed ID: 19821537
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
[TBL] [Abstract][Full Text] [Related]
4. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
Chan EL; Harris RE; Emery KH; Gelfand MJ; Collins MH; Gruppo RA
Pediatr Blood Cancer; 2007 Apr; 48(4):479-82. PubMed ID: 16333837
[TBL] [Abstract][Full Text] [Related]
5. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
[TBL] [Abstract][Full Text] [Related]
6. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Tweddle DA; Pinkerton CR; Lewis IJ; Ellershaw C; Cole M; Pearson AD
Med Pediatr Oncol; 2001 Jan; 36(1):239-42. PubMed ID: 11464894
[TBL] [Abstract][Full Text] [Related]
7. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
8. Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
Mora J; Cruz O; Lavarino C; Rios J; Vancells M; Parareda A; Salvador H; Suñol M; Carrasco R; Guillen A; Mañé S; de Torres C
Clin Transl Oncol; 2015 Jul; 17(7):521-9. PubMed ID: 25596034
[TBL] [Abstract][Full Text] [Related]
9. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Kushner BH; Yeh SD; Kramer K; Larson SM; Cheung NK
J Clin Oncol; 2003 Mar; 21(6):1082-6. PubMed ID: 12637474
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
11. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
Twist CJ; Naranjo A; Schmidt ML; Tenney SC; Cohn SL; Meany HJ; Mattei P; Adkins ES; Shimada H; London WB; Park JR; Matthay KK; Maris JM
J Clin Oncol; 2019 Jan; 37(2):115-124. PubMed ID: 30444686
[TBL] [Abstract][Full Text] [Related]
12. [Importance of gammagraphy using 131I-metaiodobenzylguanidine in the follow-up of neuroblastomas. Apropos of a case].
Ferris Tortajada J; Caballero Carpena O; Verdeguer Miralles A; Esquembre Menor C; Castel Sánchez V
An Esp Pediatr; 1986 Sep; 25(3):209-11. PubMed ID: 3789554
[No Abstract] [Full Text] [Related]
13. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
[TBL] [Abstract][Full Text] [Related]
14. Concordance for neuroblastoma in monozygotic twins: case report and review of the literature.
Tajiri T; Souzaki R; Kinoshita Y; Tanaka S; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Masumoto K; Ohira M; Nakagawara A; Taguchi T
J Pediatr Surg; 2010 Dec; 45(12):2312-6. PubMed ID: 21129536
[TBL] [Abstract][Full Text] [Related]
15. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
[TBL] [Abstract][Full Text] [Related]
16. Stage M Infantile Neuroblastoma With Involvement of Falx Cerebri: Case Report and Literature Review.
Sai M; Moriya K; Kaino A; Suzuki T; Katayama S; Aoki H; Sasahara Y
J Pediatr Hematol Oncol; 2023 May; 45(4):220-222. PubMed ID: 36161989
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Hero B; Hunneman DH; Gahr M; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):220-3. PubMed ID: 11464889
[TBL] [Abstract][Full Text] [Related]
18. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
Kaneko M; Tsuchida Y; Mugishima H; Ohnuma N; Yamamoto K; Kawa K; Iwafuchi M; Sawada T; Suita S
J Pediatr Hematol Oncol; 2002 Nov; 24(8):613-21. PubMed ID: 12439032
[TBL] [Abstract][Full Text] [Related]
19. [Relapsed stage I neuroblastoma successfully treated by allogeneic bone marrow transplantation in second remission: case report of a 7-year-old girl].
Hanada R; Yaginuma A; Hayashi Y; Inaba T; Yamamoto K; Imaizumi S; Hirata A; Sugawara T; Aihara T; Miyakawa T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1937-9. PubMed ID: 2203317
[TBL] [Abstract][Full Text] [Related]
20. CT demonstration of dural metastases in neuroblastoma.
Chirathivat S; Post MJ
J Comput Assist Tomogr; 1980 Jun; 4(3):316-9. PubMed ID: 7372864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
